Table 1.
Total | RSV | HRV | FLU | Other | |
---|---|---|---|---|---|
N (%) | N (%) | N (%) | N (%) | N (%) | |
Children <3 y with single virus ARTI | |||||
Total included | 144 | 66 | 49 | 12 | 17 |
Analysis of signs and symptoms (data available) | 138 | 64 | 46 | 11 | 17 |
Analysis of clinical outcomes (data available) | 123 | 53 | 44 | 11 | 15 |
Demographics (analysis of clinical outcomes) | |||||
Male | 76 (62) | 30 (57) | 32 (73)$ | 4 (36)$ | 10 (67) |
Mean age, months [range] | 8 [0–35] | 7 [0–35] | 7 [0–24] | 10 [1–26] | 11 [0–33] |
Median age, months [range] | 4 [0–35] | 3 [0–35] | 4 [0–24] | 9 [1–26] | 8 [0–33] |
Clinical history (analysis of clinical outcomes) | |||||
Prematurity at birth | 11 (9) | 6 (11) | 3 (7) | 1 (9) | 1 (7) |
History of BHR | 12 (9) | 5 (9) | 5 (11) | 1 (9) | 1 (7) |
Chronic pulmonary disorder | 2 (2) | 0 | 2 (5) | 0 | 0 |
Chronic cardiovascular disorder | 12 (10) | 3 (6) | 6 (14) | 1 (9) | 2 (13) |
Chronic immunodeficiency disorder | 5 (4) | 0 | 2 (5) | 1 (9) | 2 (13) |
Baseline characteristics are equally distributed, except for a male predominance with HRV vs FLU (95%CI 1.2-19)$.